These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia. Wright D; Poon LC; Rolnik DL; Syngelaki A; Delgado JL; Vojtassakova D; de Alvarado M; Kapeti E; Rehal A; Pazos A; Carbone IF; Dutemeyer V; Plasencia W; Papantoniou N; Nicolaides KH Am J Obstet Gynecol; 2017 Dec; 217(6):685.e1-685.e5. PubMed ID: 28888591 [TBL] [Abstract][Full Text] [Related]
8. Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation. O'Gorman N; Wright D; Poon LC; Rolnik DL; Syngelaki A; Wright A; Akolekar R; Cicero S; Janga D; Jani J; Molina FS; de Paco Matallana C; Papantoniou N; Persico N; Plasencia W; Singh M; Nicolaides KH Ultrasound Obstet Gynecol; 2017 Jun; 49(6):751-755. PubMed ID: 28067011 [TBL] [Abstract][Full Text] [Related]
9. Serum PlGF compared with PAPP-A in first trimester screening for preterm pre-eclampsia: Adjusting for the effect of aspirin treatment. Wright D; Tan MY; O'Gorman N; Syngelaki A; Nicolaides KH BJOG; 2022 Jul; 129(8):1308-1317. PubMed ID: 35015330 [TBL] [Abstract][Full Text] [Related]
10. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Poon LC; Shennan A; Hyett JA; Kapur A; Hadar E; Divakar H; McAuliffe F; da Silva Costa F; von Dadelszen P; McIntyre HD; Kihara AB; Di Renzo GC; Romero R; D'Alton M; Berghella V; Nicolaides KH; Hod M Int J Gynaecol Obstet; 2019 May; 145 Suppl 1(Suppl 1):1-33. PubMed ID: 31111484 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of first-trimester combined screening for early-onset and preterm pre-eclampsia at 8-10 compared with 11-13 weeks' gestation. Mendoza M; Garcia-Manau P; Arévalo S; Avilés M; Serrano B; Sánchez-Durán MÁ; Garcia-Ruiz I; Bonacina E; Carreras E Ultrasound Obstet Gynecol; 2021 Jan; 57(1):84-90. PubMed ID: 32388877 [TBL] [Abstract][Full Text] [Related]
12. Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks' gestation: comparison with NICE guidelines and ACOG recommendations. O'Gorman N; Wright D; Poon LC; Rolnik DL; Syngelaki A; de Alvarado M; Carbone IF; Dutemeyer V; Fiolna M; Frick A; Karagiotis N; Mastrodima S; de Paco Matallana C; Papaioannou G; Pazos A; Plasencia W; Nicolaides KH Ultrasound Obstet Gynecol; 2017 Jun; 49(6):756-760. PubMed ID: 28295782 [TBL] [Abstract][Full Text] [Related]
13. Competing-risks model in screening for pre-eclampsia in twin pregnancy according to maternal factors and biomarkers at 11-13 weeks' gestation. Francisco C; Wright D; Benkő Z; Syngelaki A; Nicolaides KH Ultrasound Obstet Gynecol; 2017 Nov; 50(5):589-595. PubMed ID: 28556556 [TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population. Chaemsaithong P; Pooh RK; Zheng M; Ma R; Chaiyasit N; Tokunaka M; Shaw SW; Seshadri S; Choolani M; Wataganara T; Yeo GSH; Wright A; Leung WC; Sekizawa A; Hu Y; Naruse K; Saito S; Sahota D; Leung TY; Poon LC Am J Obstet Gynecol; 2019 Dec; 221(6):650.e1-650.e16. PubMed ID: 31589866 [TBL] [Abstract][Full Text] [Related]
15. ASPRE trial: incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm. Poon LC; Rolnik DL; Tan MY; Delgado JL; Tsokaki T; Akolekar R; Singh M; Andrade W; Efeturk T; Jani JC; Plasencia W; Papaioannou G; Blazquez AR; Carbone IF; Wright D; Nicolaides KH Ultrasound Obstet Gynecol; 2018 Jun; 51(6):738-742. PubMed ID: 29380918 [TBL] [Abstract][Full Text] [Related]
17. Management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation. Litwinska M; Syngelaki A; Wright A; Wright D; Nicolaides KH Ultrasound Obstet Gynecol; 2018 Sep; 52(3):365-372. PubMed ID: 29943498 [TBL] [Abstract][Full Text] [Related]
18. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history. Poon LC; Wright D; Rolnik DL; Syngelaki A; Delgado JL; Tsokaki T; Leipold G; Akolekar R; Shearing S; De Stefani L; Jani JC; Plasencia W; Evangelinakis N; Gonzalez-Vanegas O; Persico N; Nicolaides KH Am J Obstet Gynecol; 2017 Nov; 217(5):585.e1-585.e5. PubMed ID: 28784417 [TBL] [Abstract][Full Text] [Related]
19. Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 30-34 weeks' gestation. Wright D; Dragan I; Syngelaki A; Akolekar R; Nicolaides KH Ultrasound Obstet Gynecol; 2017 Feb; 49(2):194-200. PubMed ID: 27671544 [TBL] [Abstract][Full Text] [Related]
20. Prediction of pre-eclampsia in twin pregnancy by maternal factors and biomarkers at 11-13 weeks' gestation: data from EVENTS trial. Benkő Z; Wright A; Rehal A; Cimpoca B; Syngelaki A; Delgado JL; Tsokaki T; De Alvarado M; Vojtassakova D; Malligiannis Ntalianis K; Chaveeva P; Del Campo A; De Ganzo T; Resta C; Atanasova V; Accurti V; Villalain C; Aguilera J; Dojcinovska D; O'Gorman N; Plasencia W; Zingler E; Dutemeyer V; Alvar B; Casanova MC; Nicolaides KH Ultrasound Obstet Gynecol; 2021 Feb; 57(2):257-265. PubMed ID: 33142361 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]